There was a highly significant reduction in LDL-C from baseline to Week 26 ( Fig. 2 , Table 2 ).
← all excerpts
Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia.
1
—
—
There was a highly significant reduction in LDL-C from baseline to Week 26 ( Fig. 2 , Table 2 ).